Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > To Peladawn

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Jun 22, 2024 6:38pm

44 Views

Post# 36101883

RE:RE:RE:RE:RE:RE:RE:RE:RE:To Peladawn

Well, itntdf, it seems you get easily confused between secret shell companies receiving secret deposits, and legitimate wealth funds....Jared was worth about $500 million long before he ever married Ivanka and long before Trump was in the Whitehouse.....if you can't get that far into figuring it out, it's a waste of time trying to explain it to you

<< Previous

Bullboard Posts

Next >>

Catch up with companies that got a Stanley Cup Playoffs boost